Gene expression test predicts melanoma metastasis
ORLANDO – A commercially available melanoma gene expression test had a negative predictive value of 98% for metastasis, but also correctly identified patients at very high risk of disease spread.
In a retrospective study, the DecisionDx-Melanoma test, which examines 28 risk genes, showed that...
Source: Skin and Allergy News - Category: Dermatology Source Type: news
More News: Allergy | Allergy & Immunology | Dermatology | Genetics | Melanoma | Skin | Skin Cancer | Study